Aurora Cannabis Inc (ACB) - Total Liabilities

Latest as of December 2025: $207.47 Million USD

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has total liabilities worth $207.47 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is Aurora Cannabis Inc growing its equity to track the company's year-over-year net asset growth rate.

Aurora Cannabis Inc - Total Liabilities Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Aurora Cannabis Inc to measure how efficiently the company converts operating cash flow to free cash.

Aurora Cannabis Inc Competitors by Total Liabilities

The table below lists competitors of Aurora Cannabis Inc ranked by their total liabilities.

Company Country Total Liabilities
Site Centers Corp
NYSE:SITC
USA $65.97 Million
Lucara Diamond Corp
TO:LUC
Canada CA$455.45 Million
Hanyang Securities Co Ltd
KO:001755
Korea ₩1.25 Trillion
Forte Biosciences Inc
NASDAQ:FBRX
USA $12.99 Million
Astral Resources NL
AU:AAR
Australia AU$4.92 Million
Byggma
OL:BMA
Norway Nkr2.08 Billion
Kolibri Global Energy Inc. Common stock
NASDAQ:KGEI
USA $89.90 Million
Galectin Therapeutics Inc
NASDAQ:GALT
USA $146.00 Million

Liability Composition Analysis (2007–2025)

This chart breaks down Aurora Cannabis Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ACB company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.06 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aurora Cannabis Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aurora Cannabis Inc (2007–2025)

The table below shows the annual total liabilities of Aurora Cannabis Inc from 2007 to 2025.

Year Total Liabilities Change
2025-03-31 $242.67 Million +2.30%
2024-03-31 $237.22 Million -41.38%
2023-03-31 $404.64 Million 0.00%
2022-03-31 $404.64 Million -41.01%
2021-03-31 $685.97 Million -14.53%
2020-03-31 $802.56 Million -34.95%
2019-03-31 $1.23 Billion +267.34%
2018-03-31 $335.87 Million +222.60%
2017-03-31 $104.11 Million +727.59%
2016-03-31 $12.58 Million +29.78%
2015-03-31 $9.69 Million +1707.93%
2014-03-31 $536.18K +1865.56%
2013-03-31 $27.28K -64.94%
2012-03-31 $77.81K +403.31%
2011-03-31 $15.46K +1.05%
2010-03-31 $15.30K +84.01%
2009-03-31 $8.31K +26.64%
2008-03-31 $6.57K 0.00%
2007-03-31 $6.57K --

About Aurora Cannabis Inc

NASDAQ:ACB USA Drug Manufacturers - Specialty & Generic
Market Cap
$172.06 Million
Market Cap Rank
#17143 Global
#4010 in USA
Share Price
$2.91
Change (1 day)
+3.56%
52-Week Range
$2.58 - $6.23
All Time High
$1416.62
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more